Maglinte, Cherry O.
HRN: 16-60-50 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2025
METRONIDAZOLE 500MG (TAB)
09/11/2025
09/18/2025
PO
500mg
TID
Bacterial Vaginosis
Checking Initial Appropriateness
09/11/2025
CEFUROXIME 500MG (TAB)
09/11/2025
09/18/2025
PO
500mg
BID
Bacterial Vaginosis
Checking Initial Appropriateness